Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients (Q32062370)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients (English)

1 reference

Europe PubMed Central

6 July 2017

Alzheimer's disease

0 references

0 references

author name string

Mathieu-Kia AM

1

1 reference

Europe PubMed Central

6 July 2017

Fan LQ

2

1 reference

Europe PubMed Central

6 July 2017

Kreek MJ

3

1 reference

Europe PubMed Central

6 July 2017

Simon EJ

4

1 reference

Europe PubMed Central

6 July 2017

Hiller JM

5

1 reference

Europe PubMed Central

6 July 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

893

1 reference

Europe PubMed Central

6 July 2017

1-2

1 reference

Europe PubMed Central

6 July 2017

121-134

1 reference

Europe PubMed Central

6 July 2017

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Opioid receptor density changes in Alzheimer amygdala and putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Autoradiographic localization of delta opiate receptors in rat and human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Opiate receptor avidity and cerebral blood flow in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

mu-Opioid receptor and alpha 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Increased density of mu-opioid receptors in the postmortem brain of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Regulation of immunolabelled mu-opioid receptors and protein kinase C-alpha and zeta isoforms in the frontal cortex of human opiate addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Preservation of kappa 1 opioid receptor recognition site density and regulation by G-proteins in the temporal cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Regionally selective increases in mu opioid receptor density in the brains of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Multicenter trial of naloxone in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Laminar distribution of the multiple opioid receptors in the human cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Memory retrieval enhancement by kappa opioid agonist and mu, delta antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Studies on neurotransmitter binding in senile dementia. Comparison of Alzheimer's and mixed vascular-Alzheimer's dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

The prevalence of dementia: a quantitative integration of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Medical complications in methadone patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

kappa-1 Opioid receptors of the temporal cortex are preserved in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Multiple opiate receptor in human brain: an autoradiographic investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Molecular biology of the opioid receptors: structures, functions and distributions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Effect of the kappa-receptor agonist, U-50,488H, on cerebral ischemia-induced impairment of working memory assessed in rats by a three-panel runway task.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Effects of an enkephalin analog on complex learning in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

mu-Opposing actions of the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Lack of clinical benefit from naloxone in a dementia day hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Topographical distribution of neurochemical changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Effects of naloxone in senile dementia: a double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Alterations in brain opiate receptors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Brain methionine- and leucine-enkephalin receptors in patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Endogenous opioids in frontal cortex of patients with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

[3H]naloxone binding in the human brain: alcoholism and the TaqI A D2 dopamine receptor polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Analysis of laminar distribution of kappa opiate receptor in human cortex: comparison between schizophrenia and normal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Opioid receptors in the human cerebellum: evidence from [11C]diprenorphine PET, mRNA expression and autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Systemic administration of dynorphin A-(1-13) markedly improves cycloheximide-induced amnesia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Neuropeptides in human memory and learning processes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903302-3

7 January 2021

Identifiers

10.1016/S0006-8993(00)03302-3

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32062370&oldid=1541419556"